Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Myasthenia Gravis × Immunoglobulins × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Rare Diseases 1 Neurologic Manifestations 1 Myasthenia Gravis 1 Mental Disorders 1

Interventions

telitacicept 2 bu-zhong-yi-qi-tang 1 Walk Test 1 Sugammadex 1 Robotic Surgical Procedures 1 Rituximab 1 Psychodrama 1 Population Groups 1 Neostigmine 1 Mycophenolic Acid 1 Immunoglobulins 1 Cognitive Behavioral Therapy 1 Art Therapy 1 Acupuncture Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00004682 2015-03-25

Randomized Study of Intravenous Immunoglobulin in Patients With Mild or Moderate Myasthenia Gravis

FDA Office of Orphan Products Development

Phase NA Terminated

Mental Disorders, Myasthenia Gravis, Neurologic Manifestations, Rare Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡